Elona Kogan | General Counsel |
Carsten Brunn | President and Chief Executive Officer |
Brad Dahms | Chief Financial Officer |
Kei Kishimoto | Chief Scientific Officer |
Ellie Merle | Cantor Fitzgerald |
Raju Prasad | William Blair |
Chad Messer | Needham & Company |
John Newman | Canaccord |
Yun Zhong | Janney |
Difei Yang | Mizuho Securities USA |
Good morning and welcome to the Selecta Biosciences' Fourth Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Selecta's website at www.selectabio.com and it is being recorded.
For opening remarks, I would like to introduce Elona Kogan, General Counsel of Selecta. Please go ahead.